PRABHAT SETH: Open Payments
NPI 1356383277 · MCKEESPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 43 payments from 10 companies in 2025. Trend: 2023 $726 · 2024 $814 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $193 |
| Aimmune Therapeutics, Inc. | 7 | $134 |
| Novo Nordisk Inc | 7 | $119 |
| GlaxoSmithKline, LLC. | 6 | $114 |
| PFIZER INC. | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Lilly USA, LLC | 2 | $33 |
| Seqirus USA Inc | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Pulmonx Corporation | 1 | $15 |
Products named: ZENPEP, TRELEGY ELLIPTA, PREVNAR 20, BREZTRI, JARDIANCE, Ozempic, FARXIGA, MOUNJARO.
Industry payments across PA — which companies pay providers there.
